Member Info for AnthonyW

Some fun was had with AI software today. It suggested its more than probable that these TWO are one and the same person.

Why is this person spending so much time arguing with themselves? To what end?

@porky

Why are you on the EUDA site or here for that matter?

https://stocktwits.com/Porky9/message/549970395

Porky the AIM saviour is also hanging around the US version of this - stocktwits trying to scare EUDA Investors too. Not all heroes wear capes (sic). https://stocktwits.com/Porky9/message/548200810

I wonder if you stopped responding to them they would lose oxygen and go away. As DJ says without you answering and feeding them for say 3 or 4 days see what happens to their messages. I wager they will go away?

I do own shares and am being as patient as possible.

@djframboise I suspect you'll find Calderkate would have the same IP address as the three others on here. As you say without Calderkate piping up who would they be talking to?

I wonder what Captain, Tradesin and Atan are doing here posting several times a day every day? Maybe spreadex want people to buy and sell? who knows. I think Calderkate is probably one of these people as well.

@dinoken need something like this in Belgium where tonnes of vaccines are produced

Https://uk.finance.yahoo.com/news/tiziana-life-sciences-announces-foralumab-110000776.html

@bucolic and your thoughts about why HALEON the world's largest consumer health company decided to partner with FUM?

Https://www.proactiveinvestors.co.uk/LON:FUM/Futura-Medical-PLC

Heck if HALEON like EROXON they might even want to look at FUMs diclofenac gel which looks at early stage better than HALEONs own diclofenac gel. https://www.futuramedical.com/what-we-do/pain-relief/tpr100-clinical-data/

Taking into account the US$4mln in upfront payments Futura is set to receive, Liberum has upgraded its price target from 142p to 152p.

“We still see significant upside despite the strong recent performance and remain buyers,” said Liberum.

@bottom read the RNS again.

They are being given £4millon upfront (cash worries gone) ROYALTY payments on EVERY sale PLUS performance milestones as you have mentioned below.

None bigger in consumer health than HALEON. Well done all.

GSK itself wouldn't buy FUM. HALEON their consumer spin off might but begs the question does EROXON fit in their product portfolio (ie do they have a sexual interest). I'd probably think it could be RECKITT B that it might be more likely.

Depends on the volumes. I would imagine they will be able to source an existing manufacturer if it's worth their time. Its not super complicated a product. I guess if we work with the owner of Boots (Walgreens) they might want haste and have contacts or even manufacturer themselves....

They'll use a contract manufacturer like most other pharmas. I believe in the UK they use BCM of Nottingham for UK/EU.

Anyone figure if Eroxon sells well at Boots upon FDA the parent (biggest pharmacy group in the world) Walgreens (boots owner) might take an interest in the US ?

@Wad the important bit needs to be empathised "whilst the test is being used routinely within NHS sites." Routinely means used all the time. The data part is necessary and happens with all new medical devices. It will bring money in. The review was very positive.

@jam it didn't reach 58p last week. The share will reach that level in the very near future.